TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Asia Pacific Endothelial Dysfunction Market - by Cause

1.3.2 Asia Pacific Endothelial Dysfunction Market - by Test Type

1.3.3 Asia Pacific Endothelial Dysfunction Market - by End User

1.3.4 Asia Pacific Endothelial Dysfunction Market - by Country

2. Asia Pacific Endothelial Dysfunction Market - Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Endothelial Dysfunction Market - Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Asia Pacific PEST Analysis

4.3 Expert Opinion

5. Asia Pacific Endothelial Dysfunction Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Incidences of Cardiovascular Diseases

5.1.2 Rising Incidences of High Cholesterol, Diabetes And Obesity

5.2 Market Restraints

5.2.1 Disadvantages Associated with the Techniques for Screening of Endothelial Dysfunction

5.3 Market Opportunities

5.3.1 Rising Usage of Novel Biomarkers and Therapeutic Strategies

5.4 Future Trends

5.4.1 Use of Noninvasive Methods to Assess Endothelial Dysfunction

5.5 Impact Analysis

6. Endothelial Dysfunction Market - Asia Pacific Analysis

6.1 Asia Pacific Endothelial Dysfunction Market Revenue Forecast and Analysis

7. Asia Pacific Endothelial Dysfunction Market Analysis - by Cause

7.1 Overview

7.2 Asia Pacific Endothelial Dysfunction Market, By Cause, 2022 & 2028 (%)

7.3 Hypertension

7.3.1 Overview

7.3.2 Hypertension: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

7.4 Diabetes

7.4.1 Overview

7.4.2 Diabetes: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

7.5 Hypercholestrolaemia

7.5.1 Overview

7.5.2 Hypercholestrolaemia: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

7.6 Behcet's Disease

7.6.1 Overview

7.6.2 Behcet's Disease: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

7.7 Obesity

7.7.1 Overview

7.7.2 Obesity: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

7.8 Others

7.8.1 Overview

7.8.2 Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Endothelial Dysfunction Market Analysis - by Test Type

8.1 Overview

8.2 Asia Pacific Endothelial Dysfunction Market, By Test Type, 2022 & 2028 (%)

8.3 Invasive Tests

8.3.1 Overview

8.3.2 Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8.4 Non-Invasive Tests

8.4.1 Overview

8.4.2 Non-Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8.4.3 Flow Mediated Dilatory

8.4.3.1 Overview

8.4.3.2 Flow Mediated Dilatory: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8.4.4 Venous Occlusion Plethysmography

8.4.4.1 Overview

8.4.4.2 Venous Occlusion Plethysmography: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8.4.5 Peripheral Arterial Tonometry (PAT)

8.4.5.1 Overview

8.4.5.2 Peripheral Arterial Tonometry (PAT): Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8.4.6 Circulating Markers

8.4.6.1 Overview

8.4.6.2 Circulating Markers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8.4.7 Others

8.4.7.1 Overview

8.4.7.2 Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Endothelial Dysfunction Market Analysis - by End User

9.1 Overview

9.2 Asia Pacific Endothelial Dysfunction Market, By End User, 2022 & 2028 (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

9.4 Diagnostics Centers

9.4.1 Overview

9.4.2 Diagnostics Centers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

9.5 Clinics

9.5.1 Overview

9.5.2 Clinics: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Endothelial Dysfunction Market - Revenue and Forecast to 2028 - Country Analysis

10.1 Asia Pacific: Endothelial Dysfunction Market

10.1.1 Overview

10.1.1.1 China: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 China: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.3 China: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)

10.1.1.1.4 China: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)

10.1.1.1.4.1 China: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)

10.1.1.1.5 China: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)

10.1.1.2 Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.3 Japan: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)

10.1.1.2.4 Japan: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)

10.1.1.2.4.1 Japan: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)

10.1.1.2.5 Japan: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)

10.1.1.3 India: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 India: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.3 India: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)

10.1.1.3.4 India: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)

10.1.1.3.4.1 India: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)

10.1.1.3.5 India: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)

10.1.1.4 Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 Overview

10.1.1.4.2 Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.3 Australia: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)

10.1.1.4.4 Australia: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)

10.1.1.4.4.1 Australia: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)

10.1.1.4.5 Australia: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)

10.1.1.5 South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.1 Overview

10.1.1.5.2 South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.3 South Korea: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)

10.1.1.5.4 South Korea: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)

10.1.1.5.4.1 South Korea: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)

10.1.1.5.5 South Korea: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)

10.1.1.6 Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.1 Overview

10.1.1.6.2 Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.3 Rest of Asia Pacific: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)

10.1.1.6.4 Rest of Asia Pacific: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)

10.1.1.6.4.1 Rest of Asia Pacific: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)

10.1.1.6.5 Rest of Asia Pacific: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)

11. Asia Pacific Endothelial Dysfunction Market-Industry Landscape

11.1 Overview

11.2 Growth Strategies in the Endothelial Dysfunction Market

11.3 Inorganic Growth Strategies

11.3.1 Overview

11.4 Organic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 ZOLL Medical Corp

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Sphingo Tec GmbH

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Perimed AB

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Medizinische Messtechnik GmbH

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. Techniques Used in to Assess Endothelial Function

Table 2. Novel Soluble and Cell Component Biomarkers of Endothelia Dysfunction in Cardiovascular Diseases

Table 3. China Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)

Table 4. China Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)

Table 5. China Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)

Table 6. China Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)

Table 7. Japan Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)

Table 8. Japan Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)

Table 9. Japan Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)

Table 10. Japan Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)

Table 11. India Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)

Table 12. India Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)

Table 13. India Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)

Table 14. India Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)

Table 15. Australia Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)

Table 16. Australia Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)

Table 17. Australia Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)

Table 18. Australia Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)

Table 19. South Korea Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)

Table 20. South Korea Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)

Table 21. South Korea Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)

Table 22. South Korea Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)

Table 23. Rest of Asia Pacific Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)

Table 24. Rest of Asia Pacific Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)

Table 25. Rest of Asia Pacific Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)

Table 26. Rest of Asia Pacific Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)

Table 27. Recent Inorganic Growth Strategies in the Endothelial Dysfunction Market

Table 28. Recent Organic Growth Strategies in the Endothelial Dysfunction Market

Table 29. Glossary of Terms, Endothelial dysfunction market

LIST OF FIGURES

Figure 1. Asia Pacific Endothelial Dysfunction Market Segmentation

Figure 2. Asia Pacific Endothelial Dysfunction Market, by Country

Figure 3. Asia Pacific Endothelial Dysfunction Market Overview

Figure 4. Hypertension Account for Largest Share of Cause Segment in Asia Pacific Endothelial Dysfunction Market

Figure 5. China Expected to Show Remarkable Growth During Forecast Period

Figure 6. Asia Pacific: PEST Analysis

Figure 7. Expert Opinion

Figure 8. Asia Pacific Endothelial Dysfunction Market: Impact Analysis of Drivers and Restraints

Figure 9. Asia Pacific Endothelial Dysfunction Market - Revenue Forecast and Analysis - 2020-2028

Figure 10. Asia Pacific Endothelial Dysfunction Market, by Cause, 2022 & 2028 (%)

Figure 11. Hypertension: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 12. Diabetes: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 13. Hypercholestrolaemia: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 14. Behcet's disease: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 15. Obesity: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 16. Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 17. Asia Pacific Endothelial Dysfunction Market, by Test Type, 2022 & 2028 (%)

Figure 18. Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 19. Non-Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 20. Flow Mediated Dilatory: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 21. Venous Occlusion Plethysmography: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 22. Peripheral Arterial Tonometry (PAT): Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 23. Circulating Markers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 24. Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 25. Asia Pacific Endothelial Dysfunction Market, by End User, 2022 & 2028 (%)

Figure 26. Hospitals and Clinics: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 27. Diagnostics Centers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 28. Clinics: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 29. Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 30. Asia Pacific: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)

Figure 31. Asia Pacific: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)

Figure 32. China: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)

Figure 33. Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)

Figure 34. India: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)

Figure 35. Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)

Figure 36. South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)

Figure 37. Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)

Figure 38. Growth Strategies in the Endothelial Dysfunction Market